Coding repeats are usually short mononucleotide tracts (SMT) of 10 or less base pairs in size. A number of such sequences contained in genes suspected to play a role in human carcinogenesis have been found to be mutated in mismatch repair deficient tumors (MSI-H cancers). Because of the high background of instability characterizing these cancers and in the absence of functional criteria, the significance of most frameshift gene alterations is unclear. In the present work, we analysed a series of 22 transcribed but non-coding SMT that are thus unlikely to play a tumorigenic role. Their frequency of size alteration in germline DNA and in DNA from MSI-H and microsatellite stable (MSS) tumors were compared to those previously reported in a series of 25 coding SMT of similar size. Non-coding SMT were either monomorphic or polymorphic in germline DNA whereas coding SMT were all monomorphic. In MSI-H tumors, non-coding SMT showed infrequent alterations (0 -44%), as opposed to coding SMT which were altered at extremely variable frequencies (0 to 92%). Seven of the 22 non-coding SMT were monomorphic in MSS tumors but presented size alterations in MSI-H tumors with variable frequencies (3 -28%). They were thus selected for further comparative statistical analyses for instability in coding SMT in MSI-H colorectal cancers. Only seven out of 25 of the coding SMT showed a significantly higher mutation frequency in these tumors. In the absence of functional criteria, we propose this as a novel and comprehensive approach for distinguishing real target genes amongst the numerous proposed gene mutations. It should allow identification of those that are genuinely selected for during MSI-H tumoral progression from others that play a less important role, if any, in MSI-H carcinogenesis.
Introduction
Mismatch repair (MMR) deficient cancers are tumors that accumulate thousands of somatic mutations in simple repeated sequences (Aaltonen et al., 1993; Thibodeau et al., 1993; Ionov et al., 1993) . Almost all tumors from the Human Non Polyposis Colorectal Cancer syndrome (HNPCC) are MMR deficient, as well as 10 -15% of sporadic colorectal, gastric and endometrial cancers (Boland et al., 1998) . These tumors are also referred to as MSI-H because they show a high rate of microsatellite instability, as opposed to CIN (or LOH) tumors presenting with chromosomal instability. The genes found to be mutated and thus proposed as having a tumorigenic role are different in MSI-H and LOH tumors. In MSI-H tumors, most are altered at coding repeat sequences that act as molecular targets for this specific pathway for carcinogenesis (Markowitz et al., 1995; Malkhosyan et al., 1996; Souza et al., 1996; Rampino et al., 1997; Duval et al., 1999; Schwartz et al., 1999; Kim et al., 2001 ). In colorectal MSI-H tumors, frameshift mutations in a number of genes with such coding repeats were reported to occur at varying frequencies (Duval and Hamelin, 2002) . These mutations were proposed to be selected for as recessive or dominant genetic events in these cancers. However, in the absence of functional criteria the significance of most of these events is still uncertain, especially since MSI-H tumors are characterized by a high background for instability.
Recently we performed a study of mutations in candidate genes in a large series of sporadic MSI-H colorectal cancers (Duval et al., 2001) . Twenty-five mononucleotide coding repeats (from 8 to 10 bp in size) contained within genes that had been proposed or suspected to play a role in human MSI-H carcinogenesis were analysed for mutations in these tumors. Using a likelihood statistical method, we demonstrated that genes could be separated into two different groups that differed significantly in their mutation frequencies. These were likely to represent mutations that do or do not provide selective pressures during MSI-H tumoral progression. Recently, non-coding small mononucleotide tracts (SMT) of the same nature and size were also found to be altered in MSI-H tumors with variable frequencies (Zhang et al., 2001) . These repeats were chosen in intronic sequences well away from regulatory sequences and hence are unlikely to play a tumorigenic role. According to these studies, microsatellite instability in short mononucleotide tracts appears to be a complex genetic phenomenon that depends not only on functional but also structural and possibly other as yet undefined factors.
The work presented here was aimed at better understanding this complex mutational process affecting thousands of SMT in MSI-H tumors and likely to play a crucial role during MSI-H tumoral progression. We compared the frequencies of mutations affecting both coding and non-coding SMT of the same nature and size in a large series of MSI-H colorectal cell lines and primary tumors. MMR proficient tumors and normal germline DNA were used as negative controls in order to distinguish polymorphisms from mutations. Together, these studies lead us to propose a novel concept on the mutation selection process affecting target genes for instability in these cancers. This approach should be used, in the absence of functional criteria, as an objective statistical method based on simple genetic criteria in order to test the putative involvement of proposed or new candidate target genes suspected of being involved in MSI-H carcinogenesis.
Results

Mutation analysis of coding SMT
Coding repeats of 8 to 10 bp in length contained in a total of 25 genes have already been analysed for mutations in a series of 57 sporadic colorectal MSI-H primary cancers and eight MSS cell lines (Duval et al., 2001) . All were previously shown to be monomorphic in a series of 65 MSS colorectal primary tumors, 16 MSS colorectal cell lines and 48 normal DNA samples that have been used as negative controls in this study. The majority of genes (19/25 and 22/25 in MSI-H primary tumors and cell lines respectively) were found to be altered at mutation frequencies ranging from 2 -92% in MSI-H primary tumors and from 13 -100% in cell lines.
Mutation analysis of non coding SMT MSI-H colorectal primary tumors and cell lines were also analysed for alterations at 29 non-coding SMT. These microsatellites have been reported previously (Zhang et al., 2001) and were chosen because they were: (a) comparable in their nature (single Adenosine or Guanine mononucleotide repeats) and size (eight base pairs) to the 25 coding SMT selected above; (b) localized at a distance from intron/exon borders within intronic regions of transcribed genes rather than within intergenic genomic areas because of the possible influence of some transcriptional mechanisms on the MMR process; and (c) unlikely to play a functional role in human carcinogenesis.
Seven SMT presented PCR products with multiband patterns and were thus excluded from analysis. A first estimation of size variations in MSI-H tumors at the 22 other considered loci was comparable to those reported by Zhang et al. (2001) . (i.e. between 0 -44% and 0 -80% on MSI-H primary tumors and cell lines respectively) (Table 1) . However, when we looked at the allelic profiles of these non-coding tracts in normal control DNA samples, a number of them (n=7) appeared to be polymorphic (2 -28% of samples showed length variations when compared to the major band pattern) (Table 1 ). In four cases (SMT6, SMT15, SMT16, SMT29), these tracts showed allelic length variations in more than 10% of cases. Similar results were obtained with MSS tumors and cell lines. None of these 22 SMT showed significantly more frequent size variation in MSI-H tumors (or cell lines) compared to MSS tumors (or cell lines) with the exception of SMT2 and SMT4 for cell lines. When size variations were compared between MSI-H primary tumors and additive results obtained with germline DNA and MSS primary tumors (Table 1 , P values in parenthesis), only SMT4 and SMT16 reached significant differences.
With one exception (SMT4), non-coding SMT with the more frequent size variations in MSI-H primary tumors were in the highly polymorphic group. Using a series of 17 matched normal/MSI-H tumor DNA samples, we thus evaluated true instability rates due to somatic mutation of these four highly polymorphic markers (Figure 1 ), together with instability of SMT4 and 3 other monomorphic non-coding SMT (SMT1, 2 and 5) ( Table 1) . Our observed percentages of instability for these eight SMT are much lower than those observed by Zhang et al. (2001) for the same repeats, and are similar to the results recently published by Suzuki et al. (2002) . The results of Zhang et al. (2001) were obtained without comparison of tumor DNA with matching normal DNA. In this situation, polymorphisms and mutations are additive, leading to overestimation of the instability frequency for each SMT.
Selection of non-coding SMT as internal standards for instability
Since all 22 non-coding SMT were chosen within intronic sequences and also without an expected regulatory role in mRNA stability or processing, it is likely that instability at such repeats in MSI-H cancers is determined by structural and not functional criteria. Evaluation of this phenomenon is thus expected to reflect the background of instability affecting SMT in these tumors. Seven of the SMT (SMT2, 3, 4, 10, 23, 25 and 27) mutated at variable frequencies (3 -28%) in MSI-H cancers but monomorphic in germline DNA and in tumors with proficient MMR were selected as an internal control panel. Their frequency of instability was compared with the alteration frequencies reported for the 25 proposed target gene coding repeats. Only seven of the coding SMT were mutated significantly more frequently than this non-coding SMT panel in MSI-H tumors, possibly as a result of positive selection pressures for these mutations during MSI-H tumoral progression.
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Discussion
It is widely recognized that MSI-H tumors with defects in their MMR system accumulate thousands of mutations and that most are within microsatellite repeat sequences (Aaltonen et al., 1993; Thibodeau et al., 1993; Ionvo et al., 1993) . The great majority of microsatellites are interspersed between coding sequences and variations in their size are not expected to play a role during MSI-H tumoral progression. A number of mostly short mononucleotide repeats (8 -10 bp) are however localized within the coding sequence of genes having a possible functional role in human carcinogenesis. Following the inactivation of a MMR gene, a number of such tracts have been shown to be altered at variable frequencies in MSI-H tumors. Some were proposed as being involved in MSI-H tumor development, as reported in a recent review (Duval and Hamelin, 2002) . In the absence of functional criteria, one of the main problems is to discriminate between frameshift mutations that play a role in MSI-H tumoral progression from those that occur simply due to the background of instability that characterizes these tumors. It is generally believed that 'high' instability rates observed at such coding repeats are selected for during tumoral progression because of the existence of clonal positive selection pressures. We have analysed 25 coding repeats in a large series of colorectal primary tumors and shown by a likelihood statistical approach the existence of at least two categories of genes containing repeats that differed significantly in their mutation frequencies in MSI-H cancers (Duval et al., 2001) . Using this approach we proposed an experimental cut-off frequency value (10 -15%) that divides mutational events into those that are or are not selected for during MSI-H tumor progression.
In a recent article, Zhang et al. (2001) reported that non-coding, short mononucleotide repeats of the same length and nature as the ones described for instability within coding regions of target genes could be mutated in as many as 50% of MSI-H cell lines and xenografts. Since these repeats were located in intronic sequences having no putative role in mRNA stability or processing, this high incidence of instability raised doubts on the functional significance of all previous results on mutations in target genes. Indeed, if sequences that have no obvious reason to be positively selected for during tumorigenesis can be mutated in up Instability of coding and non coding SMT in MSI-H tumors A Duval et al to 50% of MSI-H tumors, our previous cut-off value of 10 -15% mutation frequency for functional significance becomes questionable. However following analysis of the same non-coding repeats we found a much lower frequency of instability. In fact, among the 22 repeats for which we have data, seven were found to be polymorphic in normal or MSS tumoral DNA while 15 others were observed to be monomorphic in these MMR proficient samples. Since they did not systematically analyse normal DNA, we suggest that Zhang et al. (2001) overestimated the somatic mutation frequencies of these non-coding repeats by including polymorphisms in their mutation results. The same conclusion was reached recently by Suzuki et al. (2002) in their analysis of a subset of the same non-coding SMT.
We did observe however that some non-coding SMT show instability in MSI-H tumors. Taking into account these results, the SMT instability phenomenon was compared at the coding and non-coding level in MSI-H colorectal cancers by the use of seven anonymous noncoding SMT (SMT2, 3, 4, 10, 23, 25 and 27) . Their variations in allelic length were observed in MSI-H cancers but not in MMR proficient normal or tumor DNA samples. Because of these properties (monomorphic in normal DNA, no putative regulatory role, occasionally mutated in MSI-H tumors) and even if arbitrarily chosen amongst the thousands disseminated in the human genome, their level of mutation is likely to reflect the background instability affecting such microsatellites in MSI-H tumors. Hence, using the same methodological approach on the same MSI-H tumor series, they represent accurate controls for comparison of mutation frequencies with those observed in coding SMT.
Using this approach, we were able to identify which of the 25 target genes for MSI had mutation frequencies that were significantly higher than those observed for the seven non-coding anonymous tracts described above (22/240, 9.2%). Thus, only a small proportion of these 25 genes (CASP5, MSH6, IGFIIR, GRB14, BAX, TCF-4 and TGFbRII, mutated from 19.4 to 92% in MSI-H tumors) were confirmed (P value of 0.01 or lower) to be real target genes for instability in MSI-H tumors, similar to what was observed using the likelihood statistical method (Duval et al., 2001 ). According to these two different comparative statistical approaches, hMSH3, RAD-50 and RHAMM frameshift alterations were or were not found to have a significantly high level of mutation in MSI-H cancers. This demonstrates the limits of the two statistical methods that should only be considered as indicative depending on the empirical parameters used in each case. Both of them, however, underline the fact that only a fraction of the numerous coding gene mutations that occur in putative target genes for MSI appear to be selected for during tumoral progression. Because MSI-H carcinogenesis is a complex and mutigenic process, the nature as well as combination of specific gene mutations is likely to be important for determining their functional consequencies in these cancers. General cytomic approaches using gene array technologies are now necessary to be developed in order to confirm knowledge in this field.
Materials and methods
Cell lines and primary tumors
Thirty-three cell lines were obtained from Dr Sordat (Institut Suisse de Recherches Expe´rimentales sur le Cancer, Epalinges, Switzerland) and Dr Zweibaum (Villejuif, France), or purchased from the American Type Culture Collection. Primary colorectal tumors were obtained from patients undergoing surgery for colorectal cancer. These were selected from a larger series in order to increase the number of MSI-H tumors and comprised 34 MSI-H and 11 MSS tumors. Seventeen matched DNA from normal control blood and MSI-H primary tumor samples were included in this study. They were obtained from patients without family history suggestive of Hereditary Non-Polyposis Colorectal Cancer (HNPCC).
Assessment of MSI
MSI status of all the primary tumors and cell lines was assessed on the basis of the evaluation of the mononucleotide repeats BAT-26 within intron 5 of hMSH2, and BAT-25 within intron 16 of c-kit, as previously described (Hoang et al., 1997; Zhou et al., 1998) .
Analysis of non-coding SMT
Twenty-nine non-coding SMT were amplified by PCR as described (Zhang et al., 2001) . The PCR products were separated on a 7 M urea/32% formamide/7% polyacrylamide gel, transferred overnight onto Hybond N + nylon membrane and hybridized with the 32 P-labeled antisense primer in each case as a probe. SMT size variations were thus determined by the presence of additional bands to the more common allele. Non specific PCR products with multiband patterns were excluded from analysis.
